A simple alternative to prodrug: the hydrochloride salt monohydrate of the prostate anticancer drug abiraterone

Página do item simplificado
dc.creatorSilveira, Rafael Gomes da
dc.creatorCunha, Beatriz Nogueira da
dc.creatorTenorio Clavijo, Juan Carlos
dc.creatorAguiar, Deborah Victória Alves de
dc.creatorSouza, Patricia da Cruz
dc.creatorVaz, Boniek Gontijo
dc.creatorEllena, Javier Alcides
dc.creatorBatista, Alzir Azevedo
dc.creatorMartins, Felipe Terra
dc.date.accessioned2023-07-31T13:50:56Z
dc.date.available2023-07-31T13:50:56Z
dc.date.issued2019
dc.description.abstractAbiraterone acetate is a first choice prodrug to treat prostate cancer. New higher-solubility multicomponent crystal forms of the active compound abiraterone could substitute for the commonly used acetate prodrug. Here we prepare abiraterone hydrochloride monohydrate, which is the first multicomponent crystal form of this striking prostate anticancer agent. Its solid state characterization by single-crystal X-ray diffraction (SCXRD), infrared (IR) spectroscopy and thermogravimetry (TG) was performed. The only conformational difference in the molecular backbone common to the literature related crystal forms (abiraterone acetate and the free base abiraterone) and our salt resides in the 3-pyridil rotation upon protonation. If the neutral molecules found in the two literature structures are taken as references, this motif is rotated by almost exactly 180° in our protonated abiraterone. Crystal packing also follows the protonation pattern. While in both prodrug and free base there is formation of head-to-tail fashioned one-dimensional chains as the main supramolecular entities, hydrogen bonded sheets are the main supramolecular motifs of abiraterone hydrochloride monohydrate. In addition, the IR spectrum and the TG thermogram of the hydrochloride salt monohydrate are present with characteristics absorption bands and thermal events, being therefore useful as analytical data for control quality purposes of this promising active pharmaceutical ingredient.pt_BR
dc.identifier.citationSILVEIRA, Rafael G. et al. A simple alternative to prodrug: the hydrochloride salt monohydrate of the prostate anticancer drug abiraterone. Journal of Molecular Structure, Amsterdeam, v. 1190, p. 165-170, 2019. DOI: 10.1016/j.molstruc.2019.04.068. Disponível em: https://www.sciencedirect.com/science/article/abs/pii/S0022286019304715?via%3Dihub. Acesso em: 28 jun. 2023.pt_BR
dc.identifier.doi10.1016/j.molstruc.2019.04.068
dc.identifier.issne- 1872-8014
dc.identifier.issn0022-2860
dc.identifier.urihttps://www.sciencedirect.com/science/article/abs/pii/S0022286019304715?via%3Dihub
dc.language.isoengpt_BR
dc.publisher.countryHolandapt_BR
dc.publisher.departmentInstituto de Química - IQ (RMG)pt_BR
dc.rightsAcesso Restritopt_BR
dc.titleA simple alternative to prodrug: the hydrochloride salt monohydrate of the prostate anticancer drug abirateronept_BR
dc.typeArtigopt_BR

Arquivos

Licença do Pacote
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Baixar

Coleções

IQ - Artigos publicados em periódicos